Abstract:
The present disclosure is directed to hydrazinyl lipidoids, formulations thereof further comprising at least one active agent, as well as methods of delivering the at least one active agent to a target organism. The present disclosure also relates generally to methods of preparing such hydrazinyl lipidoids, their formulation with one or more active agents, and the delivery of such formulations to target organisms.
Abstract:
Die vorliegende Erfindung betrifft ein Verfahren zum Herstellen von 1-Aryl-substituierten Pyrazolen umfassend die Umsetzung von Alkoxyenonen und Enaminoketonen mit Hydrazin-Derivaten zu 1- Aryl-substituierten dihydro-1H Pyrazolen, deren Weiterreaktion unter Wasserabspaltung zu 1-Aryl substituierten -Trihalogenmethylpyrazolen und deren Weiterverarbeitung.
Abstract:
The bicycle-substituted pyrazolon-azo derivatives of formula (I) or pharmaceutical acceptable salts, hydrates or solvates thereof, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor. The definitions of substituents of formula (I) are the same as the description.
Abstract:
The present invention provides novel pyrazoles that are useful as cannabinoid receptor antagonists and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, and/or cardiometabolic disorders.
Abstract:
The invention relates to a method for producing 2-(3-pyrazolyl-oxymethylene) nitrobenzene derivatives of formula (I), wherein the substituents and indices have the meaning given in the Description, by bromination of an o-nitrotoluene of formula (II) and subsequent reaction with a 3-hydroxypyrazol of formula (IV).
Abstract:
The subject of the invention relates to compounds having structure (I), wherein: a) each R is independently alkyl having from 1 to about 7 carbon atoms; b) Z is O or N-X; c) X is selected from hydrogen, alkyl having from 1 to about 7 carbon atoms, C(O)Y, C(S)Y, and SO2Y; d) Y is selected from R', OR' and NR'2; and e) R' is selected from hydrogen, alkyl having from 1 to about 7 carbon atoms, and phenyl. The subject invention also relates to pharmaceutical compositions comprising the above compounds, and methods of treating inflammation or pain using the compounds.
Abstract:
The invention concerns 2-[(dihydro)pyrazolyl-3'-oxymethylene]-anilides of formula (I) in which -- is a single or double bond and the subscripts and substituents are as follows: n 0, 1, 2, 3 or 4; m 0, 1 or 2; X a direct bond or CH2, oxygen or NR , R being hydrogen, alkyl, alkenyl, alkinyl, cycloalkyl or cycloalkenyl; R nitro, cyano, halogen or optionally substituted alkyl, alkenyl, alkinyl, alkoxy, alkenyloxy or alkinyloxy; R nitro, cyano, halogen, alkyl, haloalkyl, alkoxy, alkylthio or alkoxycarbonyl; R optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, heterocyclyl, aryl or heteroaryl; R hydrogen or optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkenyl, alkylcarbonyl or alkoxycarbonyl; R hydrogen, alkyl, alkenyl, alkinyl, cycloalkyl or cycloalkenyl. The invention also concerns methods of preparing such compounds, intermediates used in their preparation and their use.
Abstract:
alpha -phenylbutenic acid methyl esters of formula (I) are disclosed, wherein -- represents a single or double bond and the index and substituents have the following meanings: n is 0, 1, 2, 3, or 4; R represents nitro, cyano, halogen, alkyl, alkyl halide or alkoxy; R represents hydrogen, nitro, cyano, halogen, alkyl, alkyl halide, alkoxy, alkylthio or alkoxycarbonyl; R represents optionally substituted alkyl, alkenyl or alkinyl; an optionally substituted saturated or mono or biunsaturated ring which in addition to carbon atoms can contain 1-3 heteroatoms chosen from oxygen, sulphur and nitrogen, as ring members, or an optionally, substituted mono or binuclear aromatic group which in addition to carbon atoms can contain 1-4 nitrogen atoms or one or two nitrogen atoms and an oxygen or sulphur atom or an oxygen or sulphur atom as ring members. Also disclosed is a process for the production of the claimed compounds and the use thereof against harmful fungi or animal pests.
Abstract:
The present disclosure is directed to hydrazinyl lipidoids, formulations thereof further comprising at least one active agent, as well as methods of delivering the at least one active agent to a target organism. The present disclosure also relates generally to methods of preparing such hydrazinyl lipidoids, their formulation with one or more active agents, and the delivery of such formulations to target organisms.
Abstract:
The invention provides benzenesulfonamido and related compounds, pharmaceutical compositions, methods of promoting RORγ activity, increasing the amount of IL-17 in a subject, and treating cancer using such benzenesulfonamido and related compounds.